We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MNPR market cap is 9.68M. The company's latest EPS is USD -0.5652 and P/E is -1.19.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.41M | -2.91M | -2.53M | -2.33M | -2.07M |
| Net Income | -2.4M | -2.89M | -2.44M | -2.2M | -1.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 122k | 0 | 0 | 0 |
| Operating Income | -4.32M | -6.41M | -9.13M | -10.54M | -8.83M |
| Net Income | -4.23M | -6.31M | -9.1M | -10.5M | -8.4M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.45M | 13.23M | 11.83M | 10.34M | 8.59M |
| Total Liabilities | 1.94M | 3.14M | 2.89M | 2.5M | 1.98M |
| Total Equity | 12.51M | 10.09M | 8.95M | 7.84M | 6.61M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 13.35M | 16.87M | 20.52M | 13.23M | 7.35M |
| Total Liabilities | 724k | 1.18M | 1.58M | 3.14M | 1.76M |
| Total Equity | 12.63M | 15.69M | 18.94M | 10.09M | 5.59M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.93M | -7.23M | -2.27M | -4.37M | -6.31M |
| Investing | N/A | -4.92M | -983k | 1.97M | 1.96M |
| Financing | -106k | 33k | 805k | 1.45M | 1.69M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.02M | -4.66M | -7.32M | -7.23M | -7.86M |
| Investing | N/A | N/A | N/A | -4.92M | 4.93M |
| Financing | 9.35M | 8.18M | 10.88M | 33k | 2.03M |
| Market Cap | 9.68M |
| Price to Earnings Ratio | -1.19 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.37 |
| Price to Book Ratio | 1.78 |
| Dividend Yield | - |
| Shares Outstanding | 14.87M |
| Average Volume (1 week) | 40k |
| Average Volume (1 Month) | 155.42k |
| 52 Week Change | -40.28% |
| 52 Week High | 1.75 |
| 52 Week Low | 0.2739 |
| Spread (Intraday) | 0.02 (2.84%) |
| Company Name | Monopar Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.monopartx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
